Niagen Bioscience, Inc. (NAGE): auditor change — ChromaDex appoints Crowe LLP as new independent auditor effective December 13, 2024

Niagen Bioscience, Inc.

Audit Committee approved Crowe LLP as independent auditor for fiscal year ending Dec 31, 2024, effective Dec 13, 2024.
No disagreements with prior auditor during fiscal years 2023 and 2022 and subsequent interim period.
No consultations with Crowe regarding application of accounting principles or audit opinion prior to engagement.
Change follows competitive request-for-proposal process conducted by Audit Committee.

item 4.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Niagen Bioscience, Inc. engaged Crowe LLP as its auditor.

Action: engagement
Auditor: Crowe LLP

Exact text from the filing

the Audit Committee approved the engagement of Crowe LLP (“Crowe”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024, effective December 13, 2024.

View on SEC.gov

Browse all auditor changes →

Niagen Bioscience, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-051374

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.